ADME Toxicology Testing Market is Projected to Grow by a Robust 10% through 2030 and Reach $11 billion
Industry Experts, Inc., has released its latest report on ADME Toxicology Testing Market. According this new report, the global market for ADME Toxicology Testing is estimated at US$6.3 billion in 2024 and is projected to reach US$11.2 billion by 2030, with a CAGR of 10.13% during the forecast period 2024-2030. The global ADME toxicology testing market is experiencing rapid growth, fueled by the rising rates of drug failures in late-stage clinical trials, the growing demand for innovative and personalized therapies, and more stringent regulatory conditions worldwide. ADME testing is essential for assessing pharmacokinetics, toxicokinetics, and potential toxicity early in the drug development process, which helps mitigate expensive failures and enhances safety profiles. Pharmaceutical companies are increasing their research and development spending to create safer treatments for chronic illnesses, including cancer, diabetes, and heart disease.
Like this book? You can publish your book online for free in a few
minutes!